Vimarsana
Biggest News Aggregation in the World

Optimizerx Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optimizerx Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optimizerx Co Today - Breaking & Trending Today

Millrace Asset Group Inc. Purchases Shares of 133,936 OptimizeRx Co. (NASDAQ:OPRX) - Vimarsana News

Millrace Asset Group Inc. Purchases Shares of 133,936 OptimizeRx Co. (NASDAQ:OPRX)

Millrace Asset Group Inc. purchased a new stake in OptimizeRx Co. (NASDAQ:OPRX – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 133,936 shares of the company’s stock, valued at approximately $1,917,000. OptimizeRx makes up about 1.9% of Millrace […]

OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - Vimarsana News

OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that […]

Citigroup Inc. Cuts Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Vimarsana News

Citigroup Inc. Cuts Stock Position in OptimizeRx Co. (NASDAQ:OPRX)

Citigroup Inc. decreased its position in shares of OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 45.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,189 shares of the company’s stock after selling 5,070 shares during the period. Citigroup Inc.’s […]

OptimizeRx Co. (NASDAQ:OPRX) Receives $16.00 Average Price Target from Analysts - Vimarsana News

OptimizeRx Co. (NASDAQ:OPRX) Receives $16.00 Average Price Target from Analysts

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among brokerages that […]

Source: wkrb13.com
OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from Analysts - Vimarsana News

OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Rating of "Moderate Buy" from Analysts

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price objective among analysts […]